The feasibility of the ACOSOG Z0011 Criteria to Chinese Breast Cancer Patients: A Multicenter Study

por Liu, Miao, Wang, Shu, Cui, Shude, Duan, Xuening, Fan, Zhimin, Yu, Zhigang
Publicado 2015

Restin suppressed epithelial-mesenchymal transition and tumor metastasis in breast cancer cells through upregulating mir-200a/b expression via association with p73

por Lu, Zhenduo, Jiao, Dechuang, Qiao, Jianghua, Yang, Sen, Yan, Min, Cui, Shude, Liu, Zhenzhen
Publicado 2015

Clinicopathological features and prognosis of breast cancer combined with symptomatic bone marrow metastases: A 10‐year, single‐center, real‐world study of 67 cases

por Niu, Limin, Lv, Huimin, Zhang, Mengwei, Zeng, Huiai, Fu, Shuzhen, Cui, Shude, Liu, Zhenzhen, Yan, Min
Publicado 2023

Clinical diagnosis and treatment of breast cancer with brain metastases and establishment of a prognostic model: a 10-year, single-center, real-world study of 559 cases

por Niu, Limin, Lv, Huimin, Zhang, Mengwei, Zeng, Huiai, Wang, Lifeng, Cui, Shude, Liu, Zhenzhen, Yan, Min
Publicado 2021

Outcomes of re-treatment with first-line trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after (neo)adjuvant trastuzumab: A prospective multicenter stu...

por Xu, Binghe, Hu, Xichun, Zheng, Hong, Wang, Xiaojia, Zhang, Qingyuan, Cui, Shude, Liu, Donggeng, Liao, Ning, Luo, Rongcheng, Sun, Qiang, Yu, Shiying
Publicado 2016

Use of trastuzumab as an adjuvant/neoadjuvant therapy in patients with HER2-positive breast cancer in China: The Nvwa study

por Li, Junjie, Shao, Zhimin, Xu, Binghe, Jiang, Zefei, Cui, Shude, Zhang, Jin, Liao, Ning, Jiang, Jun, Wang, Yongsheng, Ouyang, Quchang, Ying, Ziwei
Publicado 2018

Effect of the HER-2/CEP17 ratio in IHC 2+/FISH-amplified breast cancer on pathological complete response to neoadjuvant pertuzumab and trastuzumab treatment—a retrospective cohort...

por Wang, Jiabin, Qiao, Jianghua, Ruan, Yuxia, Wang, Chengzheng, Li, Lianfang, Lu, Zhenduo, Sun, Xianfu, Zhang, Chongjian, Chen, Xiuchun, Yan, Min, Cui, Shude, Liu, Zhenzhen
Publicado 2022

A Nomogram for Identifying HR+/Her2− Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted Axillary Lymph Node Dissection Who Need Abemaciclib Therapy

por Yang, Hanzhao, Sun, Yadong, Wang, Peili, Qiao, Jianghua, Li, Lianfang, Lu, Zhenduo, Sun, Xianfu, Zhang, Chongjian, Chen, Xiuchun, Yan, Min, Cui, Shude, Wang, Chengzheng, Liu, Zhenzhen
Publicado 2023

Role of locoregional surgery in patients with de novo stage IV breast cancer: analysis of real-world data from China

por Ma, Li, Mi, Yunzhe, Cui, Shude, Wang, Haibo, Fu, Peifen, Yin, Yongmei, Jin, Feng, Li, Jianbin, Liu, Yinhua, Fan, Zhimin, Zhang, Haiqing, Geng, Cuizhi, Jiang, Zefei
Publicado 2020

Neoadjuvant Efficacy of Three Targeted Therapy Strategies for HER2-Positive Breast Cancer Based on the Same Chemotherapy Regimen

por Zhu, Jiujun, Jiao, Dechuang, Wang, Chengzheng, Lu, Zhenduo, Chen, Xiuchun, Li, Lianfang, Sun, Xianfu, Qin, Li, Guo, Xuhui, Zhang, Chongjian, Qiao, Jianghua, Yan, Min, Cui, Shude, Liu, Zhenzhen
Publicado 2022

Efficacy and safety analysis of trastuzumab and paclitaxel based regimen plus carboplatin or epirubicin as neoadjuvant therapy for clinical stage II-III, HER2-positive breast cance...

por Huang, Liang, Chen, Sheng, Yang, Wentao, Xu, Binghe, Huang, Tao, Yang, Hongjian, Zheng, Hong, Wang, Yongsheng, Song, Erwei, Zhang, Jin, Cui, Shude, Pang, Da, Tang, Lili, Lei, Yutao, Geng, Cuizhi, Shao, Zhiming
Publicado 2015

Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast Cancer

por Zhu, Jiujun, Jiao, Dechuang, Yan, Min, Chen, Xiuchun, Wang, Chengzheng, Lu, Zhenduo, Li, Lianfang, Sun, Xianfu, Qin, Li, Guo, Xuhui, Zhang, Chongjian, Qiao, Jianghua, Li, Jianbin, Fan, Zhimin, Wang, Haibo, Zhang, Jianguo, Yin, Yongmei, Fu, Peifen, Geng, Cuizhi, Jin, Feng, Jiang, Zefei, Cui, Shude, Liu, Zhenzhen
Publicado 2021

Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case‐Control Study in Northern an...

por Wang, Fei, Liu, Liyuan, Cui, Shude, Tian, Fuguo, Fan, Zhimin, Geng, Cuizhi, Cao, Xuchen, Yang, Zhenlin, Wang, Xiang, Liang, Hong, Wang, Shu, Jiang, Hongchuan, Duan, Xuening, Wang, Haibo, Li, Guolou, Wang, Qitang, Zhang, Jianguo, Jin, Feng, Tang, Jinhai, Li, Liang, Zhu, Shiguang, Zuo, Wenshu, Ma, Zhongbing, Zhou, Fei, Yu, Lixiang, Xiang, Yujuan, Li, Liang, Shen, Shuohao, Yu, Zhigang
Publicado 2017

Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin Is a Potential Mechanism: A Case–Control Study in Chine...

por Xiang, Yujuan, Zhou, Wenzhong, Duan, Xuening, Fan, Zhimin, Wang, Shu, Liu, Shuchen, Liu, Liyuan, Wang, Fei, Yu, Lixiang, Zhou, Fei, Huang, Shuya, Li, Liang, Zhang, Qiang, Fu, Qinye, Ma, Zhongbing, Gao, Dezong, Cui, Shude, Geng, Cuizhi, Cao, Xuchen, Yang, Zhenlin, Wang, Xiang, Liang, Hong, Jiang, Hongchuan, Wang, Haibo, Li, Guolou, Wang, Qitang, Zhang, Jianguo, Jin, Feng, Tang, Jinhai, Tian, Fuguo, Ye, Chunmiao, Yu, Zhigang
Publicado 2020

Addendum: Metabolic Syndrome, and Particularly the Hypertriglyceridemic-Waist Phenotype, Increases Breast Cancer Risk, and Adiponectin Is a Potential Mechanism: A Case–Control Stud...

por Xiang, Yujuan, Zhou, Wenzhong, Duan, Xuening, Fan, Zhimin, Wang, Shu, Liu, Shuchen, Liu, Liyuan, Wang, Fei, Yu, Lixiang, Zhou, Fei, Huang, Shuya, Li, Liang, Zhang, Qiang, Fu, Qinye, Ma, Zhongbing, Gao, Dezong, Cui, Shude, Geng, Cuizhi, Cao, Xuchen, Yang, Zhenlin, Wang, Xiang, Liang, Hong, Jiang, Hongchuan, Wang, Haibo, Li, Guolou, Wang, Qitang, Zhang, Jianguo, Jin, Feng, Tang, Jinhai, Tian, Fuguo, Ye, Chunmiao, Yu, Zhigang
Publicado 2020

Assessment of CPS + EG, Neo-Bioscore and Modified Neo-Bioscore in Breast Cancer Patients Treated With Preoperative Systemic Therapy: A Multicenter Cohort Study

por Xu, Ling, Liu, Yinhua, Fan, Zhimin, Jiang, Zefei, Liu, Yunjiang, Ling, Rui, Zhang, Jianguo, Yu, Zhigang, Jin, Feng, Wang, Chuan, Cui, Shude, Wang, Shu, Mao, Dahua, Han, Bing, Wang, Tao, Zhang, Geng, Wang, Ting, Guo, Baoliang, Yu, Lixiang, Xu, Yingying, Fu, Fangmeng, Liu, Zhenzhen, Wang, Siyuan, Luo, Ke, Xiang, Qian, Zhang, Zhuo, Liu, Qianxin, Zhou, Bin, Liu, Zhaorui, Ma, Chao, Tong, Weiwei, Mao, Jie, Duan, Xuening, Cui, Yimin
Publicado 2021

Single-Nucleotide Polymorphisms in LEP and LEPR Associated With Breast Cancer Risk: Results From a Multicenter Case–Control Study in Chinese Females

por Li, Liang, Meng, Xingchen, Liu, Liyuan, Xiang, Yujuan, Wang, Fei, Yu, Lixiang, Zhou, Fei, Zheng, Chao, Zhou, Wenzhong, Cui, Shude, Tian, Fuguo, Fan, Zhimin, Geng, Cuizhi, Cao, Xuchen, Yang, Zhenlin, Wang, Xiang, Liang, Hong, Wang, Shu, Jiang, Hongchuan, Duan, Xuening, Wang, Haibo, Li, Guolou, Wang, Qitang, Zhang, Jianguo, Jin, Feng, Tang, Jinhai, Li, Liang, Zhu, Shiguang, Zuo, Wenshu, Ye, Chunmiao, Yin, Gengshen, Ma, Zhongbing, Huang, Shuya, Yu, Zhigang
Publicado 2022

Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial

por Li, Junjie, Yu, Keda, Pang, Da, Wang, Changqin, Jiang, Jun, Yang, Suisheng, Liu, Yunjiang, Fu, Peifen, Sheng, Yuan, Zhang, Guojun, Cao, Yali, He, Qi, Cui, Shude, Wang, Xijing, Ren, Guosheng, Li, Xinzheng, Yu, Shiyou, Liu, Pengxi, Qu, Xiang, Tang, Jinhai, Wang, Ouchen, Fan, Zhimin, Jiang, Guoqin, Zhang, Jin, Wang, Jiandong, Zhang, Hongwei, Wang, Shui, Zhang, Jianguo, Jin, Feng, Rao, Nanyan, Ma, Binlin, He, Pingqing, Xu, Binghe, Zhuang, Zhigang, Wang, Jianfeng, Sun, Qiang, Guo, Xiaofeng, Mo, Miao, Shao, Zhimin
Publicado 2020